Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anurag Relan

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|February 20, 2021
Population pharmacokinetics of recombinant human C1 esterase inhibitor in children with hereditary angioedemaSiobhán Hayes, Colm Farrell, Anurag Relan, et al.
Clinical Reviews in Allergy & Immunology|December 21, 2014
Hereditary Angioedema Attacks: Local Swelling at Multiple SitesZonne L M Hofman, Anurag Relan, C Erik Hack
Lancet (London, England)|April 12, 2018
C1 esterase inhibitor concentrates and attenuated androgens - Authors' replyMarc A Riedl, Anurag Relan, Joseph R Harper, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 13, 2017
Sustained response of recombinant human C1 esterase inhibitor for acute treatment of hereditary angioedema attacksJonathan A Bernstein, Anurag Relan, Joseph R Harper, et al.
Journal of Managed Care & Specialty Pharmacy|December 17, 2019
Modeling Cost-Effectiveness of On-Demand Treatment for Hereditary Angioedema AttacksJonathan A Bernstein, Christopher Tyson, Anurag Relan, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|August 30, 2012
Immunogenicity assessment of recombinant human c1-inhibitor: an integrated analysis of clinical studiesC Erik Hack, Maurice Mannesse, Aartie Baboeram, et al.
Allergy and Asthma Proceedings|September 7, 2017
Efficacy of recombinant human C1 esterase inhibitor for the treatment of severe hereditary angioedema attacksH Henry Li, Avner Reshef, James W Baker, et al.
Allergy and Asthma Proceedings|September 15, 2017
Recombinant human C1 esterase inhibitor for acute hereditary angioedema attacks with upper airway involvementMarc A Riedl, H Henry Li, Marco Cicardi, et al.
The Patient|April 3, 2012
Content validity of visual analog scales to assess symptom severity of acute angioedema attacks in adults with hereditary angioedema: an interview studyCarolyn Vivienne McMillan, Jane Speight, Anurag Relan, et al.
Allergy and Asthma Proceedings|June 30, 2018
Efficacy of recombinant human C1 esterase inhibitor across anatomic locations in acute hereditary angioedema attacksJames W Baker, Jonathan A Bernstein, Joseph R Harper, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|February 20, 2021
Population pharmacokinetics of recombinant human C1 esterase inhibitor in children with hereditary angioedemaSiobhán Hayes, Colm Farrell, Anurag Relan, et al.
Clinical Reviews in Allergy & Immunology|December 21, 2014
Hereditary Angioedema Attacks: Local Swelling at Multiple SitesZonne L M Hofman, Anurag Relan, C Erik Hack
Lancet (London, England)|April 12, 2018
C1 esterase inhibitor concentrates and attenuated androgens - Authors' replyMarc A Riedl, Anurag Relan, Joseph R Harper, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 13, 2017
Sustained response of recombinant human C1 esterase inhibitor for acute treatment of hereditary angioedema attacksJonathan A Bernstein, Anurag Relan, Joseph R Harper, et al.
Journal of Managed Care & Specialty Pharmacy|December 17, 2019
Modeling Cost-Effectiveness of On-Demand Treatment for Hereditary Angioedema AttacksJonathan A Bernstein, Christopher Tyson, Anurag Relan, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|August 30, 2012
Immunogenicity assessment of recombinant human c1-inhibitor: an integrated analysis of clinical studiesC Erik Hack, Maurice Mannesse, Aartie Baboeram, et al.
Allergy and Asthma Proceedings|September 7, 2017
Efficacy of recombinant human C1 esterase inhibitor for the treatment of severe hereditary angioedema attacksH Henry Li, Avner Reshef, James W Baker, et al.
Allergy and Asthma Proceedings|September 15, 2017
Recombinant human C1 esterase inhibitor for acute hereditary angioedema attacks with upper airway involvementMarc A Riedl, H Henry Li, Marco Cicardi, et al.
The Patient|April 3, 2012
Content validity of visual analog scales to assess symptom severity of acute angioedema attacks in adults with hereditary angioedema: an interview studyCarolyn Vivienne McMillan, Jane Speight, Anurag Relan, et al.
Allergy and Asthma Proceedings|June 30, 2018
Efficacy of recombinant human C1 esterase inhibitor across anatomic locations in acute hereditary angioedema attacksJames W Baker, Jonathan A Bernstein, Joseph R Harper, et al.
Pageof 4